IMMX

Immix Biopharma
IMMX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$47.40M
EV
$30.80M
Shares Outstanding
29.86M
Beta
0.29

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$7.00
P/E 2025E
-
P/Revenue 2025E
14.60x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Immix Biopharma, Inc.

gainify
IMMX

Immix Biopharma, Inc.

IMMX

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical tri...

Sector

Healthcare

Industry

Biotechnology

CEO

Rachman, Ilya

Employees

20

IPO Date

2021-12-16

Headquarters

11400 West Olympic Boulevard, Suite 200, Los Angeles, California, 90064, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved